Clinical application of bone morphogenetic proteins for bone healing: a systematic review.

Gopal Shankar Krishnakumar, Alice Roffi, Davide Reale, Elizaveta Kon, Giuseppe Filardo

Research output: Contribution to journalArticle

Abstract

PURPOSE:
This paper documents the existing evidence on bone morphogenetic proteins (BMPs) use for the treatment of bone fractures, non-union, and osteonecrosis, through a review of the clinical literature, underlying potential and limitations in terms of cost effectiveness and risk of complications.
METHODS:
A systematic review was performed on the PubMed database using the following string: (bone morphogenetic proteins OR BMPs) and (bone repair OR bone regeneration) including papers from 2000 to 2016. The search focused on clinical trials dealing with BMPs application to favor bone regeneration in bone fractures, non-union, and osteonecrosis, in English language, with level of evidence I, II, III, and IV. Relevant data (type of study, number of patients, BMPs delivery material, dose, site, follow-up, outcome, and adverse events) were extracted and analyzed.
RESULTS:
Forty-four articles met the inclusion criteria: 10 randomized controlled trials (RCTs), 7 comparative studies, 18 case series, and 9 case reports. rhBMP-2 was documented mainly for the treatment of fractures, and rhBMP-7 mainly for non-unions and osteonecrosis. Mixed results were found among RCTs and comparative papers: 11 reported positive results for BMPs augmentation, 3 obtained no significant effects, and 2 showed negative results. The only study comparing the two BMPs showed a better outcome with rhBMP-2 for non-union treatment.
CONCLUSION:
Clinical evidence on BMPs use for the treatment of fractures, non-union, and osteonecrosis is still controversial, with the few available reports being mainly of low quality. While positive findings have been described in many studies, mixed results are still present in the literature in terms of efficacy and adverse events. The difficulties in drawing clear conclusions are also due to the studies heterogeneity, mainly in terms of different BMPs applied, with different concomitant treatments for each bone pathology. Therefore, further research with well-designed studies is needed in order to understand the real potential of this biological approach to favour bone healing.
Original languageEnglish
Pages (from-to)1073-1083
Number of pages11
JournalInternational Orthopaedics
Volume41
Issue number6
DOIs
Publication statusPublished - Apr 19 2017

Fingerprint

Bone Morphogenetic Proteins
Bone and Bones
Osteonecrosis
Bone Regeneration
Bone Fractures
Bone Morphogenetic Protein 3
Randomized Controlled Trials
Therapeutics
PubMed
Cost-Benefit Analysis
Language
Clinical Trials
Databases
Pathology

Keywords

  • BMPs
  • Bone
  • Fractures
  • Non-union
  • Osteonecrosis

Cite this

Clinical application of bone morphogenetic proteins for bone healing: a systematic review. / Krishnakumar, Gopal Shankar; Roffi, Alice; Reale, Davide; Kon, Elizaveta; Filardo, Giuseppe.

In: International Orthopaedics, Vol. 41, No. 6, 19.04.2017, p. 1073-1083.

Research output: Contribution to journalArticle

Krishnakumar, Gopal Shankar ; Roffi, Alice ; Reale, Davide ; Kon, Elizaveta ; Filardo, Giuseppe. / Clinical application of bone morphogenetic proteins for bone healing: a systematic review. In: International Orthopaedics. 2017 ; Vol. 41, No. 6. pp. 1073-1083.
@article{803f19dd27c645fabb8cac742a425cf5,
title = "Clinical application of bone morphogenetic proteins for bone healing: a systematic review.",
abstract = "PURPOSE:This paper documents the existing evidence on bone morphogenetic proteins (BMPs) use for the treatment of bone fractures, non-union, and osteonecrosis, through a review of the clinical literature, underlying potential and limitations in terms of cost effectiveness and risk of complications.METHODS:A systematic review was performed on the PubMed database using the following string: (bone morphogenetic proteins OR BMPs) and (bone repair OR bone regeneration) including papers from 2000 to 2016. The search focused on clinical trials dealing with BMPs application to favor bone regeneration in bone fractures, non-union, and osteonecrosis, in English language, with level of evidence I, II, III, and IV. Relevant data (type of study, number of patients, BMPs delivery material, dose, site, follow-up, outcome, and adverse events) were extracted and analyzed.RESULTS:Forty-four articles met the inclusion criteria: 10 randomized controlled trials (RCTs), 7 comparative studies, 18 case series, and 9 case reports. rhBMP-2 was documented mainly for the treatment of fractures, and rhBMP-7 mainly for non-unions and osteonecrosis. Mixed results were found among RCTs and comparative papers: 11 reported positive results for BMPs augmentation, 3 obtained no significant effects, and 2 showed negative results. The only study comparing the two BMPs showed a better outcome with rhBMP-2 for non-union treatment.CONCLUSION:Clinical evidence on BMPs use for the treatment of fractures, non-union, and osteonecrosis is still controversial, with the few available reports being mainly of low quality. While positive findings have been described in many studies, mixed results are still present in the literature in terms of efficacy and adverse events. The difficulties in drawing clear conclusions are also due to the studies heterogeneity, mainly in terms of different BMPs applied, with different concomitant treatments for each bone pathology. Therefore, further research with well-designed studies is needed in order to understand the real potential of this biological approach to favour bone healing.",
keywords = "BMPs, Bone, Fractures, Non-union, Osteonecrosis",
author = "Krishnakumar, {Gopal Shankar} and Alice Roffi and Davide Reale and Elizaveta Kon and Giuseppe Filardo",
year = "2017",
month = "4",
day = "19",
doi = "10.1007/s00264-017-3471-9",
language = "English",
volume = "41",
pages = "1073--1083",
journal = "International Orthopaedics",
issn = "0341-2695",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Clinical application of bone morphogenetic proteins for bone healing: a systematic review.

AU - Krishnakumar, Gopal Shankar

AU - Roffi, Alice

AU - Reale, Davide

AU - Kon, Elizaveta

AU - Filardo, Giuseppe

PY - 2017/4/19

Y1 - 2017/4/19

N2 - PURPOSE:This paper documents the existing evidence on bone morphogenetic proteins (BMPs) use for the treatment of bone fractures, non-union, and osteonecrosis, through a review of the clinical literature, underlying potential and limitations in terms of cost effectiveness and risk of complications.METHODS:A systematic review was performed on the PubMed database using the following string: (bone morphogenetic proteins OR BMPs) and (bone repair OR bone regeneration) including papers from 2000 to 2016. The search focused on clinical trials dealing with BMPs application to favor bone regeneration in bone fractures, non-union, and osteonecrosis, in English language, with level of evidence I, II, III, and IV. Relevant data (type of study, number of patients, BMPs delivery material, dose, site, follow-up, outcome, and adverse events) were extracted and analyzed.RESULTS:Forty-four articles met the inclusion criteria: 10 randomized controlled trials (RCTs), 7 comparative studies, 18 case series, and 9 case reports. rhBMP-2 was documented mainly for the treatment of fractures, and rhBMP-7 mainly for non-unions and osteonecrosis. Mixed results were found among RCTs and comparative papers: 11 reported positive results for BMPs augmentation, 3 obtained no significant effects, and 2 showed negative results. The only study comparing the two BMPs showed a better outcome with rhBMP-2 for non-union treatment.CONCLUSION:Clinical evidence on BMPs use for the treatment of fractures, non-union, and osteonecrosis is still controversial, with the few available reports being mainly of low quality. While positive findings have been described in many studies, mixed results are still present in the literature in terms of efficacy and adverse events. The difficulties in drawing clear conclusions are also due to the studies heterogeneity, mainly in terms of different BMPs applied, with different concomitant treatments for each bone pathology. Therefore, further research with well-designed studies is needed in order to understand the real potential of this biological approach to favour bone healing.

AB - PURPOSE:This paper documents the existing evidence on bone morphogenetic proteins (BMPs) use for the treatment of bone fractures, non-union, and osteonecrosis, through a review of the clinical literature, underlying potential and limitations in terms of cost effectiveness and risk of complications.METHODS:A systematic review was performed on the PubMed database using the following string: (bone morphogenetic proteins OR BMPs) and (bone repair OR bone regeneration) including papers from 2000 to 2016. The search focused on clinical trials dealing with BMPs application to favor bone regeneration in bone fractures, non-union, and osteonecrosis, in English language, with level of evidence I, II, III, and IV. Relevant data (type of study, number of patients, BMPs delivery material, dose, site, follow-up, outcome, and adverse events) were extracted and analyzed.RESULTS:Forty-four articles met the inclusion criteria: 10 randomized controlled trials (RCTs), 7 comparative studies, 18 case series, and 9 case reports. rhBMP-2 was documented mainly for the treatment of fractures, and rhBMP-7 mainly for non-unions and osteonecrosis. Mixed results were found among RCTs and comparative papers: 11 reported positive results for BMPs augmentation, 3 obtained no significant effects, and 2 showed negative results. The only study comparing the two BMPs showed a better outcome with rhBMP-2 for non-union treatment.CONCLUSION:Clinical evidence on BMPs use for the treatment of fractures, non-union, and osteonecrosis is still controversial, with the few available reports being mainly of low quality. While positive findings have been described in many studies, mixed results are still present in the literature in terms of efficacy and adverse events. The difficulties in drawing clear conclusions are also due to the studies heterogeneity, mainly in terms of different BMPs applied, with different concomitant treatments for each bone pathology. Therefore, further research with well-designed studies is needed in order to understand the real potential of this biological approach to favour bone healing.

KW - BMPs

KW - Bone

KW - Fractures

KW - Non-union

KW - Osteonecrosis

U2 - 10.1007/s00264-017-3471-9

DO - 10.1007/s00264-017-3471-9

M3 - Article

VL - 41

SP - 1073

EP - 1083

JO - International Orthopaedics

JF - International Orthopaedics

SN - 0341-2695

IS - 6

ER -